Intranasal Oxytocin for Infants With Prader-Willi Syndrome
Condition(s):Prader-Willi SyndromeLast Updated:March 26, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Prader-Willi SyndromeLast Updated:March 26, 2020Completed
Condition(s):Mild Cognitive Impairment; Alzheimer’s Disease (AD)Last Updated:April 9, 2020Terminated
Condition(s):Prader-Willi SyndromeLast Updated:June 1, 2023Completed
Condition(s):Frontotemporal DementiaLast Updated:August 8, 2018Completed
Condition(s):Conscious SedationLast Updated:August 16, 2017Unknown status
Condition(s):Antiviral Prophylaxis; Respiratory Syncytial Virus InfectionLast Updated:March 1, 2019Completed
Condition(s):AnesthesiaLast Updated:August 30, 2017Completed
Condition(s):Covid19; COVID-19 Lower Respiratory Infection; COVID-19 Respiratory InfectionLast Updated:October 19, 2022Withdrawn
Condition(s):HealthyLast Updated:July 14, 2011Completed
Condition(s):MigraineLast Updated:March 19, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.